Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilan Merdler

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 2, 2023
Impact of IVUS and OCT on physician decision-making during post-PCI optimizationSukhdeep Bhogal, Hayder Hashim, Ilan Merdler, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 25, 2025
Cardiac mechanics in patients with coronary microvascular dysfunctionIlan Merdler, Anita Sadeghpour, Kalyan R Chitturi, et al.
The American Journal of Cardiology|September 10, 2023
Aspirin Versus Warfarin after Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Follow-UpIlan Merdler, Toby Rogers, Brian C Case, et al.
The Israel Medical Association Journal : IMAJ|July 12, 2021
Prognostic Implication of Tricuspid Regurgitation in ST-segment Elevation Myocardial Infarction PatientsBen Sadeh, Tamar Itach, Ilan Merdler, et al.
The American Journal of Cardiology|May 8, 2025
Corrigendum to Impella Versus Non-Impella for Nonemergent High-Risk Percutaneous Coronary Intervention The American Journal of Cardiology (2024) Volume 225, 15 August. Pages 4-9. DOI: 10.1016/j.amjcard.2024.05.038Pavan Reddy, Ilan Merdler, Cheng Zhang, et al.
Cardiorenal Medicine|March 11, 2020
Neutrophil Gelatinase-Associated Lipocalin for the Early Prediction of Acute Kidney Injury in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary InterventionIlan Merdler, Keren-Lee Rozenfeld, David Zahler, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 28, 2025
Adverse events and failure modes related to Impella CP: Insights from the FDA MAUDE databaseKalyan R Chitturi, Ryan Wallace, Abhishek Chaturvedi, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 29, 2024
Impact of left bundle branch block or permanent pacemaker after transcatheter aortic valve replacement on mid-term left ventricular ejection fractionIlan Merdler, Brian C Case, Itsik Ben-Dor, et al.
The Israel Medical Association Journal : IMAJ|December 26, 2021
Prognostic Implication of Tricuspid Regurgitation in ST-segment Elevation Myocardial Infarction PatientsBen Sadeh, Tamar Itach, Ilan Merdler, et al.
Journal of Cardiology|October 21, 2024
The impact of ventricular remodeling on quality-of-life outcomes after Transcatheter aortic valve replacementPavan Reddy, Kalyan R Chitturi, Ilan Merdler, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 2, 2023
Impact of IVUS and OCT on physician decision-making during post-PCI optimizationSukhdeep Bhogal, Hayder Hashim, Ilan Merdler, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 25, 2025
Cardiac mechanics in patients with coronary microvascular dysfunctionIlan Merdler, Anita Sadeghpour, Kalyan R Chitturi, et al.
The American Journal of Cardiology|September 10, 2023
Aspirin Versus Warfarin after Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Follow-UpIlan Merdler, Toby Rogers, Brian C Case, et al.
The Israel Medical Association Journal : IMAJ|July 12, 2021
Prognostic Implication of Tricuspid Regurgitation in ST-segment Elevation Myocardial Infarction PatientsBen Sadeh, Tamar Itach, Ilan Merdler, et al.
The American Journal of Cardiology|May 8, 2025
Corrigendum to Impella Versus Non-Impella for Nonemergent High-Risk Percutaneous Coronary Intervention The American Journal of Cardiology (2024) Volume 225, 15 August. Pages 4-9. DOI: 10.1016/j.amjcard.2024.05.038Pavan Reddy, Ilan Merdler, Cheng Zhang, et al.
Cardiorenal Medicine|March 11, 2020
Neutrophil Gelatinase-Associated Lipocalin for the Early Prediction of Acute Kidney Injury in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary InterventionIlan Merdler, Keren-Lee Rozenfeld, David Zahler, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 28, 2025
Adverse events and failure modes related to Impella CP: Insights from the FDA MAUDE databaseKalyan R Chitturi, Ryan Wallace, Abhishek Chaturvedi, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 29, 2024
Impact of left bundle branch block or permanent pacemaker after transcatheter aortic valve replacement on mid-term left ventricular ejection fractionIlan Merdler, Brian C Case, Itsik Ben-Dor, et al.
The Israel Medical Association Journal : IMAJ|December 26, 2021
Prognostic Implication of Tricuspid Regurgitation in ST-segment Elevation Myocardial Infarction PatientsBen Sadeh, Tamar Itach, Ilan Merdler, et al.
Journal of Cardiology|October 21, 2024
The impact of ventricular remodeling on quality-of-life outcomes after Transcatheter aortic valve replacementPavan Reddy, Kalyan R Chitturi, Ilan Merdler, et al.
Pageof 13